Noninvasive prenatal diagnosis of 21-Hydroxylase deficiency using target capture sequencing of maternal plasma DNA
Abstract Here, we aimed to validate a noninvasive method using capture sequencing for prenatal diagnosis of congenital adrenal hyperplasia due to 21-Hydroxylase deficiency (21-OHD). Noninvasive prenatal diagnosis (NIPD) of 21-OHD was based on 14 plasma samples collected from 12 families, including f...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6f8ea90d5ab74192bfe5b60cee12ff4b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:6f8ea90d5ab74192bfe5b60cee12ff4b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:6f8ea90d5ab74192bfe5b60cee12ff4b2021-12-02T16:07:45ZNoninvasive prenatal diagnosis of 21-Hydroxylase deficiency using target capture sequencing of maternal plasma DNA10.1038/s41598-017-06828-22045-2322https://doaj.org/article/6f8ea90d5ab74192bfe5b60cee12ff4b2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-06828-2https://doaj.org/toc/2045-2322Abstract Here, we aimed to validate a noninvasive method using capture sequencing for prenatal diagnosis of congenital adrenal hyperplasia due to 21-Hydroxylase deficiency (21-OHD). Noninvasive prenatal diagnosis (NIPD) of 21-OHD was based on 14 plasma samples collected from 12 families, including four plasma sample collected during the first trimester. Targeted capture sequencing was performed using genomic DNA from the parents and child trios to determine the pathogenic and wild-type alleles associated with the haplotypes. Maternal plasma DNA was also sequenced to determine the fetal inheritance of the allele using hidden Markov model-based haplotype linkage analysis. The effect of fetal DNA fraction and sequencing depth on the accuracy of NIPD was investigated. The lower limit of fetal DNA fraction was 2% and the threshold mean sequence depth was 38, suggesting potential advantage if used in early gestation. The CYP21A2 genotype of the fetus was accurately determined in all the 14 plasma samples as early as day 1 and 8 weeks of gestation. Results suggest the accuracy and feasibility of NIPD of 21-OHD using a small target capture region with a low threshold for fetal DNA fraction and sequence depth. Our method is cost-effective and suggests diagnostic applications in clinical practice.Dingyuan MaYuan YuanChunyu LuoYaoshen WangTao JiangFengyu GuoJingjing ZhangChao ChenYun SunJian ChengPing HuJian WangHuanming YangXin YiWei WangAsanZhengfeng XuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Dingyuan Ma Yuan Yuan Chunyu Luo Yaoshen Wang Tao Jiang Fengyu Guo Jingjing Zhang Chao Chen Yun Sun Jian Cheng Ping Hu Jian Wang Huanming Yang Xin Yi Wei Wang Asan Zhengfeng Xu Noninvasive prenatal diagnosis of 21-Hydroxylase deficiency using target capture sequencing of maternal plasma DNA |
| description |
Abstract Here, we aimed to validate a noninvasive method using capture sequencing for prenatal diagnosis of congenital adrenal hyperplasia due to 21-Hydroxylase deficiency (21-OHD). Noninvasive prenatal diagnosis (NIPD) of 21-OHD was based on 14 plasma samples collected from 12 families, including four plasma sample collected during the first trimester. Targeted capture sequencing was performed using genomic DNA from the parents and child trios to determine the pathogenic and wild-type alleles associated with the haplotypes. Maternal plasma DNA was also sequenced to determine the fetal inheritance of the allele using hidden Markov model-based haplotype linkage analysis. The effect of fetal DNA fraction and sequencing depth on the accuracy of NIPD was investigated. The lower limit of fetal DNA fraction was 2% and the threshold mean sequence depth was 38, suggesting potential advantage if used in early gestation. The CYP21A2 genotype of the fetus was accurately determined in all the 14 plasma samples as early as day 1 and 8 weeks of gestation. Results suggest the accuracy and feasibility of NIPD of 21-OHD using a small target capture region with a low threshold for fetal DNA fraction and sequence depth. Our method is cost-effective and suggests diagnostic applications in clinical practice. |
| format |
article |
| author |
Dingyuan Ma Yuan Yuan Chunyu Luo Yaoshen Wang Tao Jiang Fengyu Guo Jingjing Zhang Chao Chen Yun Sun Jian Cheng Ping Hu Jian Wang Huanming Yang Xin Yi Wei Wang Asan Zhengfeng Xu |
| author_facet |
Dingyuan Ma Yuan Yuan Chunyu Luo Yaoshen Wang Tao Jiang Fengyu Guo Jingjing Zhang Chao Chen Yun Sun Jian Cheng Ping Hu Jian Wang Huanming Yang Xin Yi Wei Wang Asan Zhengfeng Xu |
| author_sort |
Dingyuan Ma |
| title |
Noninvasive prenatal diagnosis of 21-Hydroxylase deficiency using target capture sequencing of maternal plasma DNA |
| title_short |
Noninvasive prenatal diagnosis of 21-Hydroxylase deficiency using target capture sequencing of maternal plasma DNA |
| title_full |
Noninvasive prenatal diagnosis of 21-Hydroxylase deficiency using target capture sequencing of maternal plasma DNA |
| title_fullStr |
Noninvasive prenatal diagnosis of 21-Hydroxylase deficiency using target capture sequencing of maternal plasma DNA |
| title_full_unstemmed |
Noninvasive prenatal diagnosis of 21-Hydroxylase deficiency using target capture sequencing of maternal plasma DNA |
| title_sort |
noninvasive prenatal diagnosis of 21-hydroxylase deficiency using target capture sequencing of maternal plasma dna |
| publisher |
Nature Portfolio |
| publishDate |
2017 |
| url |
https://doaj.org/article/6f8ea90d5ab74192bfe5b60cee12ff4b |
| work_keys_str_mv |
AT dingyuanma noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT yuanyuan noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT chunyuluo noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT yaoshenwang noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT taojiang noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT fengyuguo noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT jingjingzhang noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT chaochen noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT yunsun noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT jiancheng noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT pinghu noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT jianwang noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT huanmingyang noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT xinyi noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT weiwang noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT asan noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna AT zhengfengxu noninvasiveprenataldiagnosisof21hydroxylasedeficiencyusingtargetcapturesequencingofmaternalplasmadna |
| _version_ |
1718384722616254464 |